Thymoquinone, as an anticancer molecule: from basic research to clinical investigation

Md. Asaduzzaman Khan; Mousumi Tania; Shangyi Fu; Junjiang Fu

doi:10.18632/oncotarget.17206

journal article Apr 18, 2017

Thymoquinone, as an anticancer molecule: from basic research to clinical investigation

Md. Asaduzzaman Khan Mousumi Tania Shangyi Fu Junjiang Fu

Oncotarget Vol. 8 No. 31 pp. 51907-51919 · Impact Journals, LLC

View at Publisher Save 10.18632/oncotarget.17206

Topics

No keywords indexed for this article. Browse by subject →

References

102

[1]

Jemal "Cancer treatment and survivorship statistics, 2016" CA Cancer J Clin (2016) 10.3322/caac.21349

[2]

He "Cancer statistics in China, 2015" CA Cancer J Clin (2016) 10.3322/caac.21338

[3]

Sarkar "From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond" Cancer Ther (2008)

[4]

Zhang "Anticancer activities of Nigella sativa (black cumin)" Afr J Tradit Complement Altern Med (2011)

[5]

Anwar "A review on therapeutic potential of Nigella sativa: A miracle herb" Asian Pac J Trop Biomed (2013) 10.1016/s2221-1691(13)60075-1

[6]

Dönmez "Ancient nigella seeds from Boyali Höyük in north-central Turkey" J Ethnopharmacol (2009) 10.1016/j.jep.2009.05.039

[7]

Anand "Potential of spice-derived phytochemicals for cancer prevention" Planta Med (2008) 10.1055/s-2008-1074578

[8]

Crooks "High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.)" J Pharm Biomed Anal (1999) 10.1016/s0731-7085(98)00300-8

[9]

Tucci "The physiological effect of conventional treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid on the LNCaP cell line" Biomed Sci Instrum (2006)

[10]

Tucci "A comparison of the morphological changes associated with conventional and sustained treatment with pigallocatechin3gallate, thymoquinone, and tannic acid on lncap cells" Biomed Sci Instrum (2008)

[11]

Gali-Muhtasib "Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells" Cancer Biol Ther (2007) 10.4161/cbt.6.2.3575

[12]

Uddin "Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma" Free Radic Biol Med (2011) 10.1016/j.freeradbiomed.2010.12.034

[13]

Gali-Muhtasib "Thymoquinone induces apoptosis in malignant T-cells via generation of ROS" Front Biosci (Elite Ed) (2013)

[14]

Heikal "Thymoquinone triggers anti-apoptotic signaling targeting death ligand and apoptotic regulators in a model of hepatic ischemia reperfusion injury" Drug Discov Ther (2009)

[15]

Hadi "Redox cycling of endogenous copper by thymoquinone leads to ROS-mediated DNA breakage and consequent cell death: putative anticancer mechanism of antioxidants" Cell Death Dis (2013) 10.1038/cddis.2013.172

[16]

Eleuteri "Effects of thymoquinone on isolated and cellular proteasomes" FEBS J (2010) 10.1111/j.1742-4658.2010.07629.x

[17]

Batra "Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies" Mol Cancer Ther (2010) 10.1158/1535-7163.mct-10-0075

[18]

Mu "Interaction of human telomeric G-quadruplex DNA with thymoquinone: a possible mechanism for thymoquinone anticancer effect" Biochim Biophys Acta (2015) 10.1016/j.bbagen.2014.10.018

[19]

Hande "Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells" PLoS One (2010) 10.1371/journal.pone.0012124

[20]

Reddy "Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer" Cancer Res (2007) 10.1158/0008-5472.can-07-1483

[21]

Berg "Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions" Chem Biol (2008) 10.1016/j.chembiol.2008.03.013

[22]

Sethi "Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway" Br J Pharmacol (2010) 10.1111/j.1476-5381.2010.00874.x

[23]

Abu-Tarboush "Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XL expression" Lipids Health Dis (2011) 10.1186/1476-511x-10-236

[24]

Dong "Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathwayand" World J Gastroenterol (2016) 10.3748/wjg.v22.i16.4149

[25]

Chun "Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src mediated phosphorylation of EGF receptor tyrosine kinase" Oncol Rep (2014) 10.3892/or.2014.3223

[26]

Huang "Thymoquinone induces apoptosis in oral cancer cells through p38β inhibition" Am J Chin Med (2013) 10.1142/s0192415x1350047x

[27]

Mandal "Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells" Life Sci (2013) 10.1016/j.lfs.2013.09.009

[28]

Fuhrmann "Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1" Biochem Pharmacol (2010) 10.1016/j.bcp.2009.12.015

[29]

Lugnier "Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis" Cell Signal (2011) 10.1016/j.cellsig.2010.08.015

[30]

Ibrahim "Thymoquinone induces mitochondria-mediated apoptosis in acute lymphoblastic leukaemia" Molecules (2013) 10.3390/molecules180911219

[31]

Bahramian "Effect of Thymoquinone on P53 Gene Expression and Consequence Apoptosis in Breast Cancer Cell Line" Int J Prev Med (2016) 10.4103/2008-7802.180412

[32]

Adhikary "PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a" Biomaterials (2015) 10.1016/j.biomaterials.2015.01.007

[33]

Meltzer "TQ inhibits hepatocellular carcinoma growthandvia repression of Notch signaling" Oncotarget (2015) 10.18632/oncotarget.5362

[34]

Aly "Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways" Evid Based Complement Alternat Med (2014) 10.1155/2014/724658

[35]

Aggarwal "Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis" Mol Cancer Res (2008) 10.1158/1541-7786.mcr-07-2088

[36]

Rishi "Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression" Mol Cell Biochem (2016) 10.1007/s11010-016-2703-4

[37]

Arafat "Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells" HPB (Oxford) (2009) 10.1111/j.1477-2574.2009.00059.x

[38]

Mohany "Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis" PLoS One (2011) 10.1371/journal.pone.0023741

[39]

Attia "Thymoquinone, the active ingredient of Nigella sativa seeds, enhances survival and activity of antigen-specific CD8-positive T cells" Br J Biomed Sci (2011) 10.1080/09674845.2011.11730340

[40]

Al-Kuraya "Phosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release" PLoS One (2013) 10.1371/journal.pone.0060540

[41]

Wani "Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells" PLoS One (2013) 10.1371/journal.pone.0072882

[42]

Chen "Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy" PLoS One (2014) 10.1371/journal.pone.0101579

[43]

Huang "Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38" J Agric Food Chem (2015) 10.1021/jf5054063

[44]

Schini-Kerth "Anti-neoplastic agent thymoquinone induces degradation of α and β tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts" Invest New Drugs (2012) 10.1007/s10637-011-9734-1

[45]

Rishi "Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis" Mol Cell Biochem (2014) 10.1007/s11010-013-1930-1

[46]

Jiang "Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas bothand" Oncol Rep (2014) 10.3892/or.2014.3059

[47]

Schneider-Stock "Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer" Mol Cancer (2014) 10.1186/1476-4598-13-201

[48]

Rondé "Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation" Invest New Drugs (2012) 10.1007/s10637-011-9777-3

[49]

Yusuf "Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome" Toxicol Appl Pharmacol (2013) 10.1016/j.taap.2013.03.027

[50]

Yan "Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway" Tumour Biol (2015) 10.1007/s13277-014-2628-z

Showing 50 of 102 references

Cited By

199

Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axis

Shaymaa A. Abdulmalek, Fatma A. Mahmoud · 2025

Discover Oncology

Thymoquinone has a synergistic effect with PHD inhibitors to ameliorate ischemic brain damage in mice

Nashwa Amin, Shijia Chen · 2022

Phytomedicine

Standard Thermochemical Characteristics of Combustion and Formation of Bulky Benzoquinone-Type Derivatives at T = 298.15 K

Kira I. Pashanova, Polina E. Goryunova · 2021

Journal of Chemical & Engineeri...

Content and Composition of Wild Bergamot (Monarda fistulosa L.) Essential Oil at Different Phenological Phases

E. L. Malankina, A. N. Kuzmenko · 2020

Moscow University Chemistry Bulleti...

Thymoquinone (2-Isopropyl-5-methyl-1, 4-benzoquinone) as a chemopreventive/anticancer agent: Chemistry and biological effects

Anas Ahmad, Rakesh Kumar Mishra · 2019

Saudi Pharmaceutical Journal

Oxidation of Monoterpenes Catalysed by a Water‐Soluble MnIII PEG‐Porphyrin in a Biphasic Medium

Cláudia M. B. Neves, João P. C. Tomé · 2018

ChemCatChem

Metrics

199

Citations

102

References

Details

Published: Apr 18, 2017
Vol/Issue: 8(31)
Pages: 51907-51919

Authors

M

Md. Asaduzzaman Khan

Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China; Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, Vietnam

M

Mousumi Tania

Division of Computer Aided Drug Design, The Red-Green Computing Centre, Dhaka, Bangladesh

S

Shangyi Fu

The Honors College, University of Houston, Houston, Texas, United States

J

Junjiang Fu

Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China

Cite This Article

Md. Asaduzzaman Khan, Mousumi Tania, Shangyi Fu, et al. (2017). Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget, 8(31), 51907-51919. https://doi.org/10.18632/oncotarget.17206

Thymoquinone, as an anticancer molecule: from basic research to clinical investigation

You May Also Like